BioAffinity Technologies Inc

Research BioAffinity Technologies Inc (BIAF) on Bullrun: market cap USD 3.64M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerBIAF
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryDiagnostics & Research
• CurrencyUSD
• Market capUSD 3.64M
• Financial periodFY2025
• RevenueUSD 6.16M
• Revenue growth-34.2%
• Net income-USD 14.91M
• Free cash flow-USD 9.39M

Valuation Snapshot

latest market cap is USD 3.64M.

About BioAffinity Technologies Inc

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services.

Frequently asked questions

What is BioAffinity Technologies Inc's market cap?

BioAffinity Technologies Inc's market capitalization is USD 3.64M.

What does BioAffinity Technologies Inc do?

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States.